World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
109
Citations
45887
World Ranking
5761
National Ranking
3096

Overview

Andrew J. Carroll is affiliated with the University of Alabama at Birmingham in the United States. Their research primarily focuses on the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions in related subfields such as Hematology, Public Health, Environmental and Occupational Health, Molecular Biology, Pediatrics, Perinatology and Child Health, and Genetics.

They have been involved in investigating key topics related to leukemia and cancer, including:

  • Acute Lymphoblastic Leukemia research
  • Acute Myeloid Leukemia Research
  • Childhood Cancer Survivors' Quality of Life
  • Chronic Myeloid Leukemia Treatments
  • Histone Deacetylase Inhibitors Research
  • Lymphoma Diagnosis and Treatment
  • Myeloproliferative Neoplasms: Diagnosis and Treatment

Andrew J. Carroll has contributed to various high-impact publication venues characterized by the frequency of their publications, including:

  • Blood
  • Journal of Clinical Oncology
  • Leukemia
  • Blood Advances
  • bioRxiv (Cold Spring Harbor Laboratory)

Recent notable papers authored or coauthored by Andrew J. Carroll cover critical advances in leukemia research. Key recent publications are:

  • The genomic landscape of pediatric acute lymphoblastic leukemia, 2022, Nature Genetics
  • Children's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia, 2020, Journal of Clinical Oncology
  • Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children, 2024, New England Journal of Medicine
  • Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/ KMT2A, 2020, Proceedings of the National Academy of Sciences
  • Additional gene mutations may refine the 2017 European LeukemiaNet classification in adult patients with de novo acute myeloid leukemia aged <60 years, 2020, Leukemia

Collaboration is an important component of their research, with frequent coauthors including Mignon L. Loh, Meenakshi Devidas, Nyla A. Heerema, Elizabeth A. Raetz, and Stephen P. Hunger.

Best Publications

  • Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

    John C. Byrd;Krzysztof Mrózek;Richard K. Dodge;Andrew J. Carroll

  • Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia

    K. G. Roberts;Y. Li;D. Payne-Turner;R. C. Harvey

  • Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.

    M Smith;D Arthur;B Camitta;A J Carroll

  • The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia

    Yu Liu;John Easton;Ying Shao;Jamie Maciaszek

  • Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study.

    Michael J. Borowitz;Meenakshi Devidas;Stephen P. Hunger;W. Paul Bowman;W. Paul Bowman

  • IDH1 and IDH2 Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study

    Guido Marcucci;Kati Maharry;Yue-Zhong Wu;Michael D. Radmacher

  • Absence of the Wild-Type Allele Predicts Poor Prognosis in Adult de Novo Acute Myeloid Leukemia with Normal Cytogenetics and the Internal Tandem Duplication of FLT3 A Cancer and Leukemia Group B Study

    Susan P. Whitman;Kellie J. Archer;Lan Feng;Claudia Baldus

  • Frequency of Prolonged Remission Duration after High-Dose Cytarabine Intensification in Acute Myeloid Leukemia Varies by Cytogenetic Subtype

    Clara D. Bloomfield;David Lawrence;John C. Byrd;Andrew Carroll

  • Adverse Prognostic Significance of KIT Mutations in Adult Acute Myeloid Leukemia With inv(16) and t(8;21): A Cancer and Leukemia Group B Study

    Peter Paschka;Guido Marcucci;Amy S. Ruppert;Krzysztof Mrózek

  • Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study

    Kirk R. Schultz;W. Paul Bowman;Alexander Aledo;William B. Slayton

  • The genomic landscape of hypodiploid acute lymphoblastic leukemia

    Linda Holmfeldt;Lei Wei;Ernesto Diaz-Flores;Michael Walsh

  • Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia

    Richard C. Harvey;Richard C. Harvey;Charles G. Mullighan;I-Ming Chen;I-Ming Chen;Walker Wharton

  • Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)

    Kirk R. Schultz;D. Jeanette Pullen;Harland N. Sather;Jonathan J. Shuster

  • Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome.

    Richard C. Harvey;Richard C. Harvey;Charles G. Mullighan;Xuefei Wang;Kevin K. Dobbin

  • MicroRNA expression in cytogenetically normal acute myeloid leukemia

    Guido Marcucci;Michael D. Radmacher;Michael D. Radmacher;Kati Maharry;Kati Maharry;Krzysztof Mrózek

  • Prognostic Significance of the European LeukemiaNet Standardized System for Reporting Cytogenetic and Molecular Alterations in Adults With Acute Myeloid Leukemia

    Krzysztof Mrózek;Guido Marcucci;Deedra Nicolet;Kati S. Maharry

  • Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group study AALL0031.

    K. R. Schultz;A. Carroll;N. A. Heerema;W. P. Bowman

  • Favorable Prognostic Impact of NPM1 Mutations in Older Patients With Cytogenetically Normal De Novo Acute Myeloid Leukemia and Associated Gene- and MicroRNA-Expression Signatures: A Cancer and Leukemia Group B Study

    Heiko Becker;Guido Marcucci;Kati Maharry;Michael D. Radmacher

  • Prognostic Factors and Outcome of Core Binding Factor Acute Myeloid Leukemia Patients With t(8;21) Differ From Those of Patients With inv(16): A Cancer and Leukemia Group B Study

    Guido Marcucci;Krzysztof Mrózek;Amy S. Ruppert;Kati Maharry

  • Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in a cooperative pediatric oncology group study-POG 8821.

    S C Raimondi;M N Chang;Y Ravindranath;F G Behm

Frequent Co-Authors

Clara D. Bloomfield
Clara D. Bloomfield The Ohio State University
Stephen P. Hunger
Stephen P. Hunger University of Pennsylvania
Nyla A. Heerema
Nyla A. Heerema The Ohio State University
Krzysztof Mrózek
Krzysztof Mrózek The Ohio State University
Meenakshi Devidas
Meenakshi Devidas St. Jude Children's Research Hospital
Jonathan E. Kolitz
Jonathan E. Kolitz Hofstra University
William L. Carroll
William L. Carroll New York University
Bayard L. Powell
Bayard L. Powell Wake Forest University
Mignon L. Loh
Mignon L. Loh University of California, San Francisco
Michael J. Borowitz
Michael J. Borowitz Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering studying Medicine in the USA, there are various related online options and career pathways worth exploring. For those already holding an RN license, cheap rn to bsn online programs can be a flexible and affordable way to advance your nursing career without leaving your job.

Non-nurses or those with degrees in other fields may be interested in direct entry online msn programs, which offer an accelerated route into nursing and advanced practice roles. Admission to nursing schools varies, and applicants looking for accessible options should consider nursing programs with high acceptance rates.

Not all healthcare jobs require a clinical background; fields such as medical billing and coding offer rewarding and stable careers. You can find flexible training through medical billing and coding schools online with financial aid.

Exploring these alternative degrees and certifications can open doors in healthcare while providing multiple routes to enter this in-demand industry.

Best Scientists Citing Andrew J. Carroll

Trending Scientists